PAF-acetylhydrolase

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NamePAF-acetylhydrolase
Drug Alias NamerPAF-AH乙酰水解酶EpafipaseSUN Y7016Platelet-activating factor acetylhydrolase +[8] 
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionPlatelet activating factor receptor antagonists
TargetsPlatelet activating factor receptor
Therapy Area/IndicationsSepsis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIcos Corporation
Active IndicationsN/A
Inactive IndicationsSepsis

Other Information

ATC CodeN/A
Related LinksN/A